Correction to Prevalence of type I Gaucher disease in patients with smoldering or multiple myeloma: Results from the prospective, observational CHAGAL study

Documents similaires

• Prevalence of type I Gaucher disease in patients with smoldering or multiple myeloma: Results from the prospective, observational CHAGAL study
  par: Sonia Morè, et autres
  Publié: (2025)
• Navigating the evolving management of smoldering multiple myeloma
  par: M. Bakri Hammami, et autres
  Publié: (2026)
• The evolving pattern of the monoclonal protein improves the IMWG 2/20/20 classification for patients with smoldering multiple myeloma
  par: Anna de Daniel, et autres
  Publié: (2024)
• Daratumumab‐based quadruplet for patients with extramedullary multiple myeloma: Results from the Phase II prospective EMN19 study
  par: Meral Beksac, et autres
  Publié: (2026)
• 30‐Minute infusion of isatuximab in patients with newly diagnosed multiple myeloma: Results of a Phase 1b study analysis
  par: Enrique M. Ocio, et autres
  Publié: (2024)